A Registry for Patients Treated on the Clinical Trial TAX 3503

Completed

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to continue follow-up on patients who were treated on the study called TAX 3505 (MSK IRB #07-101). The sponsor of this study, has decided to end the study early, before all patients have completed all planned follow-up tests. As a result, the investigators do not yet know whether hormonal therapy alone, or in combination with docetaxel, is better at preventing prostate cancer recurrence in patients who had a rising PSA after prostatectomy. This study will continue following patients according to a schedule that is similar to that found in the TAX 3503 (MSK IRB #07-101) study in order to answer that question. This study is known as a registry study. The patients' will not receive any treatment as part of this study. Instead, they will be asked to have a blood test performed once every 12 weeks.

Key facts

Study ID

NCT01813370

Run by

Memorial Sloan Kettering Cancer Center

People needed

52

Starts

2013-03-01

Expected to finish

2022-03-04

Last updated by the study team

2022-03-08

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• The registry will include the database of all patients registered to TAX3503. Those patients who will be prospectively tracked through the registry are those who meet the following criteria:
• The patient must have been registered to TAX3503
• The patient must not have met the definition of progression as defined in TAX3503 while on TAX3503 Patients who have progressed or hit their 36 month post treatment date between the closure of TAX3503 and the activation of this TAX3503 Registry protocol will be permitted on the study to capture their date of progression or their 36 month post treatment progression free date.

You may not qualify if…

• Patients who were not registered to TAX3503 are not eligible to have their data stored in this registry.

Where it is running

• John Hopkins Medical Center — Baltimore, Maryland, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Urological Associates of Lancaster — Lancaster, Pennsylvania, United States
• Carolina Urologic Research Center — Myrtle Beach, South Carolina, United States
• Cancer Care Manitoba — Winnipeg, Manitoba, Canada
• Hospital of Lithuanian University Health Sciences Kauno Klinikos — Kaunas, Klinikos, Lithuania
• Klaipeda University Hospital — Klaipėda, Lithuania

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.